Mutational analysis of CALGB 40601 (Alliance), a neoadjuvant phase III trial of weekly paclitaxel (T) and trastuzumab (H) with or without+/- lapatinib (L) for HER2-positive breast cancer
- Citation:
- Cancer Res vol 75 (9 Supplement ) abstr S3-06
- Meeting Instance:
- SABCS 2014
- Year:
- 2015
- Type:
- Abstract
- Sub type:
- Oral
- Funding:
- NCTN
- Endpoint:
- Secondary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- Yes
- SDC:
- No
- Parents:
- None
- Children:
- 2304
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Katherine A. Hoadley William T. Barry Brandelyn N. Pitcher Joel S. Parker Matthew D. Wilkerson William Irvin N. Lynn Henry Sara M. Tolaney Chau Dang Ian E. Krop Donald A. Berry Elaine R. Mardis Charles M. Perou Eric P. Winer Clifford A. Hudis Lisa A. Carey
- Networks:
- Study
- CALGB-40601
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: